The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC).
 
Jenny F. Seligmann
Honoraria - Merck Serono; Pierre Fabre; SERVIER
Consulting or Advisory Role - Pierre Fabre; Zentalis
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex
 
Enric Domingo
No Relationships to Disclose
 
David Fisher
No Relationships to Disclose
 
Faye Elliott
No Relationships to Disclose
 
Louise C. Brown
Research Funding - AstraZeneca (Inst)
 
Matthew T. Seymour
Research Funding - Amgen (Inst); AstraZeneca (Inst)
 
Susan Richman
No Relationships to Disclose
 
Philip Quirke
Honoraria - Roche
Consulting or Advisory Role - Adlai Nortye; Amgen; Avacta Life Sciences; Bayer; Colonode; Roche
Research Funding - GeneFirst; ONI; Roche
Patents, Royalties, Other Intellectual Property - Roche have fileds a patent jointly with my University I may receive income but none to date (Inst)
Travel, Accommodations, Expenses - amgen; Bayer; Bayer; Roche
 
Rachel Butler
No Relationships to Disclose
 
Helen Roberts
No Relationships to Disclose
 
Carme Camps
No Relationships to Disclose
 
Pamela Kaisaki
No Relationships to Disclose
 
David N. Church
Consulting or Advisory Role - MSD
Research Funding - HalioDx (Inst)
 
David James Kerr
Employment - Celleron Therapeutics
Leadership - Oxford cancer biomarkers
Stock and Other Ownership Interests - cancer care commission; Celleron Therapeutics; Oxford cancer biomarkers
Consulting or Advisory Role - Geno Bio; Indivumed; Medscape
Speakers' Bureau - Novartis
Patents, Royalties, Other Intellectual Property - patents pending on two biomarker tests developed for Oxford Cancer Biomarkers
 
Rachel Kerr
No Relationships to Disclose
 
Richard H. Wilson
Honoraria - Amgen; Bristol-Myers Squibb; SERVIER
Consulting or Advisory Role - Amgen; Amphista Therapeutics (Inst); CV6 Therapeutics; Nucana (Inst); Pierre Fabre
Travel, Accommodations, Expenses - Amgen; Pierre Fabre
 
Oliver Sieber
No Relationships to Disclose
 
Jenny Taylor
No Relationships to Disclose
 
Ian Tomlinson
No Relationships to Disclose
 
Tim Maughan
No Relationships to Disclose